Literatur

Einmal pro Woche stellt HIV.NET wichtige Arbeiten vor. Die ausführliche Publikationsliste der Woche finden Sie auf der Literatur-Seite.

Wenn Sie bereits bei Amedeo HIV Infection eingeschrieben sind und die Zeitschriften neu zusammenstellen möchten, klicken Sie bitte hier.

22. November 2008

Pantazis N , Touloumi G, Vanhems P, Gill J, et al.
The effect of antiretroviral treatment of different durations in primary HIV infection.
AIDS. 2008;22:2441-2450.
Abstract

Stephan C , Wolf T, Goetsch U, Bellinger O, et al.
Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
AIDS. 2008;22:2471-9.
Abstract

Phillips AN , Neaton J, Lundgren JD.
The role of HIV in serious diseases other than AIDS.
AIDS. 2008;22:2409-2418.
Abstract

Harrigan PR , Sheen CW, Gill VS, Wynhoven B, et al.
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency.
AIDS. 2008;22:2501-2508.
Abstract

Engsig FN , Hansen AB, Omland LH, Kronborg G, et al.
Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study.
J Infect Dis. 2008.
Abstract

11. November 2008

Wilkin TJ , Gulick RM.
When to Start Antiretroviral Therapy?
Clin Infect Dis. 2008.
Abstract

Keiser O , Gayet-Ageron A, Rudin C, Brinkhof MW, et al.
Antiretroviral treatment during pregnancy.
AIDS. 2008;22:2323-30.
Abstract

Rollins NC , Becquet R, Bland RM, Coutsoudis A, et al.
Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes.
AIDS. 2008;22:2349-57.
Abstract

Lima VD , Harrigan R, Murray M, Moore DM, et al.
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
AIDS. 2008;22:2371-80.
Abstract

Greenbaum AH , Wilson LE, Keruly JC, Moore RD, et al.
Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.
AIDS. 2008;22:2331-9.
Abstract

Reekie J , Mocroft A, Sambatakou H, Machala L, et al.
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
AIDS. 2008;22:2381-90.
Abstract

Brown E , Chi BH, Read JS, Taha TE, et al.
Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.
AIDS. 2008;22:2341-6.
Abstract

Goff SP , .
Knockdown screens to knockout HIV-1.
Cell. 2008;135:417-20.
Abstract

Wagner TA , Frenkel LM.
Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1.
AIDS. 2008;22:2393-5.
Abstract

5. November 2008

Cantrell RA , Sinkala M, Megazinni K, Lawson-Marriott S, et al.
A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia.
J Acquir Immune Defic Syndr. 2008;49:190-5.
Abstract

Tedaldi E , Peters L, Neuhaus J, Puoti M, et al.
Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study.
Clin Infect Dis. 2008.
Abstract

Novitsky V , Lagakos S, Herzig M, Bonney C, et al.
Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.
Virology. 2008.
Abstract

Taylor BS , Hammer SM.
The challenge of HIV-1 subtype diversity.
N Engl J Med. 2008;359:1965-6.
Abstract

28. Oktober 2008

Joos B , Fischer M, Kuster H, Pillai SK, et al.
HIV rebounds from latently infected cells, rather than from continuing low-level replication.
Proc Natl Acad Sci U S A. 2008.
Abstract

Hatano H , Delwart EL, Norris PJ, Lee TH, et al.
Evidence for Persistent Low-level Viremia in Individuals Who Control HIV in the Absence of Antiretroviral Therapy.
J Virol. 2008.
Abstract

Olupot-Olupot P , Katawera A, Cooper C, Small W, et al.
Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: a qualitative study.
AIDS. 2008;22:1882-4.
Abstract

21. Oktober 2008

Quinn TC , .
HIV epidemiology and the effects of antiviral therapy on long-term consequences.
AIDS. 2008;22 Suppl 3:S7-12.
Abstract

Sitbon O , .
HIV-related pulmonary arterial hypertension: clinical presentation and management.
AIDS. 2008;22 Suppl 3:S55-62.
Abstract

Bosque A , Planelles V.
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells.
Blood. 2008.
Abstract

Guillevin L , .
Vasculitides in the context of HIV infection.
AIDS. 2008;22 Suppl 3:S27-33.
Abstract

Boccara F , .
Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
AIDS. 2008;22 Suppl 3:S19-26.
Abstract

Lederman MM , Sereni D, Simonneau G, Voelkel NF, et al.
Pulmonary arterial hypertension and its association with HIV infection: an overview.
AIDS. 2008;22 Suppl 3:S1-6.
Abstract

15. Oktober 2008

Millett GA , Flores SA, Marks G, Reed JB, et al.
Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis.
JAMA. 2008;300:1674-84.
Abstract

Lodwick RK , Smith CJ, Youle M, Lampe FC, et al.
Stability of antiretroviral regimens in patients with viral suppression.
AIDS. 2008;22:1039-46.
Abstract

Dienstag JL .
Hepatitis B virus infection.
N Engl J Med. 2008;359:1486-500.
Abstract

Stekler J , Sycks BJ, Holte S, Maenza J, et al.
HIV Dynamics in Seminal Plasma during Primary HIV Infection.
AIDS Res Hum Retroviruses. 2008.
Abstract

Gazzola L , Bini T, Pietrogrande L, Uziel L, et al.
Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.
AIDS. 2008;22:1094-7.
Abstract

Hamza OJ , Matee MI, Bruggemann RJ, Moshi MJ, et al.
Single-Dose Fluconazole versus Standard 2-Week Therapy for Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized, Double-Blind, Double-Dummy Trial.
Clin Infect Dis. 2008.
Abstract

11. Oktbober 2008

Nachega JB , Hislop M, Dowdy DW, Gallant JE, et al.
Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
AIDS. 2008;22:2117-25.
Abstract

Cozzi-Lepri A , Phillips AN, Clotet B, Mocroft A, et al.
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
AIDS. 2008;22:2187-2198.
Abstract

Benhammou V , Warszawski J, Bellec S, Doz F, et al.
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
AIDS. 2008;22:2165-2177.
Abstract

Gallant JE , Winston JA, Dejesus E, Pozniak AL, et al.
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
AIDS. 2008;22:2155-2163.
Abstract

Modjarrad K , Chamot E, Vermund SH.
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.
AIDS. 2008;22:2179-85.
Abstract

Monforte A , Abrams D, Pradier C, Weber R, et al.
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
AIDS. 2008;22:2143-53.
Abstract

Petersen ML , van der Laan MJ, Napravnik S, Eron JJ, et al.
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.
AIDS. 2008;22:2097-106.
Abstract

4. Oktober 2008

Bae WH , Wester C, Smeaton LM, Shapiro RL, et al.
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
AIDS. 2008;22:1633-40.
Abstract

Young B , Squires K, Patel P, Dejesus E, et al.
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
AIDS. 2008;22:1673-5.
Abstract

Kotler DP , .
HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
J Acquir Immune Defic Syndr. 2008;49 Suppl 2:S79-85.
Abstract

van Baarle D , Nanlohy NM, Otto S, Plunkett FJ, et al.
Progressive Telomere Shortening of Epstein-Barr Virus-Specific Memory T Cells during HIV Infection: Contributor to Exhaustion?
J Infect Dis. 2008.
Abstract

Mathers BM , Degenhardt L, Phillips B, Wiessing L, et al.
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.
Lancet. 2008.
Abstract

21. September 2008

Thein HH , Yi Q, Dore GJ, Krahn MD, et al.
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
AIDS. 2008;22:1979-1991.
Abstract

Fontella R , Soares MA, Schrago CG.
On the origin of HIV-1 subtype C in South America.
AIDS. 2008;22:2001-2011.
Abstract

Lawn SD , Harries AD, Anglaret X, Myer L, et al.
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.
AIDS. 2008;22:1897-1908.
Abstract

Willig JH , Abroms S, Westfall AO, Routman J, et al.
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.
AIDS. 2008;22:1951-1960.
Abstract

9. September 2008

Soriano V , Mocroft A, Rockstroh J, Ledergerber B, et al.
Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV-Infected Patients with Anti-HCV Antibodies in Europe.
J Infect Dis. 2008.
Abstract

El-Sadr WM , Grund B, Neuhaus J, Babiker A, et al.
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
Ann Intern Med. 2008;149:289-99.
Abstract

Santiago ML , Montano M, Benitez R, Messer RJ, et al.
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Science. 2008;321:1343-6.
Abstract

Jacobson JM , Saag MS, Thompson MA, Fischl MA, et al.
Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults.
J Infect Dis. 2008.
Abstract

6. September 2008

Molina JM , Andrade-Villanueva J, Echevarria J, Chetchotisakd P, et al.
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
Lancet. 2008;372:646-55.
Abstract

, .
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
AIDS. 2008.
Abstract

Ter Brake O , von Eije KJ, Berkhout B.
Probing the sequence space available for HIV-1 evolution.
AIDS. 2008.
Abstract

Raymond S , Delobel P, Mavigner M, Cazabat M, et al.
Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
AIDS. 2008.
Abstract

Miedema F , .
A brief history of HIV vaccine research: stepping back to the drawing board?
AIDS. 2008;22:1699-703.
Abstract

27. August 2008

Spear GT , Sikaroodi M, Zariffard MR, Landay AL, et al.
Comparison of the Diversity of the Vaginal Microbiota in HIV-Infected and HIV-Uninfected Women with or without Bacterial Vaginosis.
J Infect Dis. 2008.
Abstract

Zembower TR , Gerzenshtein L, Coleman K, Palella FJ Jr, et al.
Severe rhabdomyolysis associated with raltegravir use.
AIDS. 2008;22:1382-4.

Stringer E , Antonsen E.
Hormonal Contraception and HIV Disease Progression.
Clin Infect Dis. 2008.
Abstract

Perdomo MF , Levi M, Sallberg M, Vahlne A, et al.
Neutralization of HIV-1 by redirection of natural antibodies.
Proc Natl Acad Sci U S A. 2008.
Abstract

20. August 2008

Mitnick CD , Shin SS, Seung KJ, Rich ML, et al.
Comprehensive treatment of extensively drug-resistant tuberculosis.
N Engl J Med. 2008;359:563-74.
Abstract

Boulle A , Van Cutsem G, Cohen K, Hilderbrand K, et al.
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
JAMA. 2008;300:530-9.
Abstract

Silverman JG , Decker MR, Saggurti N, Balaiah D, et al.
Intimate partner violence and HIV infection among married Indian women.
JAMA. 2008;300:703-10.
Abstract

Samleerat T , Braibant M, Jourdain G, Moreau A, et al.
Characteristics of HIV Type 1 (HIV-1) Glycoprotein 120 env Sequences in Mother-Infant Pairs Infected with HIV-1 Subtype CRF01_AE.
J Infect Dis. 2008.
Abstract

Gupta GR , Parkhurst JO, Ogden JA, Aggleton P, et al.
Structural approaches to HIV prevention.
Lancet. 2008.
Abstract

11. August 2008

MARCELIN AG , Tubiana R, Lambert-Niclot S, Lefebvre G, et al
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
AIDS. 2008;22:1677-9.
Abstract

KAPLAN RC , Kingsley LA, Gange SJ, Benning L, et al
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
AIDS. 2008;22:1615-24.
Abstract

WALSON JL , Otieno PA, Mbuchi M, Richardson BA, et al
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
AIDS. 2008;22:1601-9.
Abstract

KINGSLEY LA , Cuervo-Rojas J, Munoz A, Palella FJ, et al
Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.
AIDS. 2008;22:1589-99.
Abstract

4. August 2008

Antiretroviral Therapy Cohort Collaboration
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
Lancet. 2008;372:293-9.
Abstract

FAUCI AS , Johnston MI, Dieffenbach CW, Burton DR, et al
HIV vaccine research: the way forward.
Science. 2008;321:530-2.
Abstract

STRINGER JS , Chi BH
Extended nevirapine prophylaxis to prevent HIV transmission.
Lancet. 2008;372:267-9.
Full-text (nach kostenloser Einschreibung)

HOLLINGSWORTH TD , Anderson RM, Fraser C
HIV-1 Transmission, by Stage of Infection.
J Infect Dis. 2008.
Abstract

WILSON DP , Law MG, Grulich AE, Cooper DA, et al
Relation between HIV viral load and infectiousness: a model-based analysis.
Lancet. 2008;372:314-20.
Abstract

LIU J , Bartesaghi A, Borgnia MJ, Sapiro G, et al
Molecular architecture of native HIV-1 gp120 trimers.
Nature. 2008.
Abstract

29. Juli 2008

• STEIGBIGEL RT , Cooper DA, Kumar PN, Eron JE, et al
  Raltegravir with optimized background therapy for resistant HIV-1 infection.
  N Engl J Med. 2008;359:339-54.
  Free full-text

• WODAK A , McLeod L
  The role of harm reduction in controlling HIV among injecting drug users.
  AIDS. 2008;22 Suppl 2:S81-92.
  Abstract

• MAHAJAN AP , Sayles JN, Patel VA, Remien RH, et al
  Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward.
  AIDS. 2008;22 Suppl 2:S67-79.
  Abstract

• BEBELL LM , Passmore JA, Williamson C, Mlisana K, et al
  Relationship between Levels of Inflammatory Cytokines in the Genital Tract and CD4(+) Cell Counts in Women with Acute HIV-1 Infection.
  J Infect Dis. 2008.
  Abstract

• TENORIO AR , Martinson J, Pollard D, Baum L, et al
  The Relationship of T-Regulatory Cell Subsets to Disease Stage, Immune Activation, and Pathogen-Specific Immunity in HIV Infection.
  J Acquir Immune Defic Syndr. 2008.
  Abstract

23. Juli 2008

• L'HOMME RF , Kabamba D, Ewings FM, Mulenga V, et al
  Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
  AIDS. 2008;22:557-65.
  PubMed     Related articles

• LOH L , Kent SJ
  Quantification of Simian Immunodeficiency Virus Cytotoxic T-Lymphocyte Escape Mutant Viruses.
  AIDS Res Hum Retroviruses. 2008;.
  PubMed     Related articles

• LEW W , Pai M, Oxlade O, Martin D, et al
  Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.
  Ann Intern Med. 2008;149:123-34.
  PubMed     Related articles